Company: CPMV
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001683168-25-002584
Chunk: 565

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 4
Chunk 565
---
  
     – 
  
    Forfeited 
     (31,444) 
     (3.21)
  
    Nonvested at December 31, 2024 
     510,513  
    $3.00 

As of December 31, 2024, there was no unrecognized
compensation cost related to RSUs. As of December 31, 2024, 14,044 RSUs have vested under the 2020 Plan since its adoption.

10.        Income Taxes

The provision (benefit) for income taxes for the years ended December
31, 2024 and 2023 is as follows:

    Schedule of provision (benefit) for income
    taxes 

    Year Ended
                                                                                December 31, 2024  
    Year Ended
                                                                                December 31, 2023 
  
    Current: 

    Federal 
    $–  
    $– 
  
    State 
     2,400  
     2,400 
  
    Total current 
     2,400  
     2,400 

    Deferred: 

    Federal 
     –  
     – 
  
    State 
     –  
     – 
  
    Total deferred 
     –  
     – 

    Total provision 
    $2,400  
    $2,400 

     F-20 

    Mosaic ImmunoEngineering, Inc.

    Notes to Consolidated Financial Statements
    For the Years Ended December 31, 2024 and 2023 (continued)

The reconciliation of the effective income tax rate
to the Federal statutory rate for the years ended December 31, 2024 and 2023 is as follows:

    Schedule of effective income tax rate 

    December 31, 2024  
    December 31, 2023 
  
    Statutory federal income tax rate 
     21.00%  
     21.00% 
  
    State income tax rate, net of Federal effect 
     (0.21%) 
     (0.19%)
  
    Fair market value of derivative liability 
     0.00%  
     0.98% 
  
    Other 
     (2.34%) 
     (0.33%)
  
    Change in valuation allowance 
     (